Neuroprotection of naloxone against ischemic injury in rats: role of mu receptor antagonism. (Q48263384)

10 February 2018

title

Neuroprotection of naloxone against ischemic injury in rats: role of mu receptor antagonism. (English)

1 reference

10 February 2018

author name string

Su-Lan Liao

1

1 reference

10 February 2018

Wen-Yin Chen

2

1 reference

10 February 2018

Shue-Ling Raung

3

1 reference

10 February 2018

Chun-Jung Chen

4

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 July 2003

1 reference

10 February 2018

published in

Neuroscience Letters

1 reference

10 February 2018

volume

345

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

169-172

1 reference

10 February 2018

Evaluation of delayed treatment of focal cerebral ischemia with three selective kappa-opioid agonists in cats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

Prevention of cocaine-induced hyperactivity by a naloxone isomer with no opiate antagonist activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

Effects of naloxone on lactate, pyruvate metabolism and antioxidant enzyme activity in rat cerebral ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

Cerebral ischemia/reperfusion injury in rat brain: effects of naloxone.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

Stereospecific blocking effects of naloxone against hemodynamic compromise and ventricular dysfunction due to myocardial ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

Naloxone blockade of myocardial ischemic preconditioning is stereoselective.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

Excitotoxic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

A double blind trial of naloxone in the treatment of acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

Dynorphin A-(1-13) potently prevents memory dysfunctions induced by transient cerebral ischemia in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

Naloxone administration to patients with acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

Endogenous opioid system in developing normal and jimpy oligodendrocytes: mu and kappa opioid receptors mediate differential mitogenic and growth responses

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

Inhibition by naloxone stereoisomers of beta-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

Effects of opioids on the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

Molecular pharmacology of the opioid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

Naloxone therapy during focal cerebral ischemia evaluation in a primate model

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900540-8

7 January 2021

10.1016/S0304-3940(03)00540-8

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

12842283

1 reference

10 February 2018